Medicare Enrolled
Dr. Donald Rediker, M.D.
Cardiovascular Disease · Mission Viejo, CA
Practice pattern: Remote & Electrophysiology
— Practice combining remote and electrophysiology services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Rediker from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Rediker?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Rediker
Dr. Donald Rediker is a cardiovascular disease specialist in Mission Viejo, CA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Rediker performed 2,458 Medicare services across 1,579 unique beneficiaries.
Between the years covered by Open Payments, Dr. Rediker received a total of $9,171 from 44 pharmaceutical and/or device companies across 513 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Rediker is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 42% volume in CA
$9,171 industry payments
Medicare Practice Summary
Medicare Utilization ↗2,458
Medicare services
Top 42% in CA for cardiovascular disease
1,579
Unique beneficiaries
$64
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~123 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
483 | $102 | $345 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
360 | $66 | $245 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
220 | $43 | $512 |
| Remote pacemaker/defibrillator monitoring, 90 days Remote evaluation of a pacemaker or implantable defibrillator system within 90 days of the last check. |
188 | $20 | $68 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
152 | $171 | $566 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
143 | $23 | $79 |
| Heart muscle strain imaging | 120 | $34 | $108 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
86 | $12 | $39 |
| Remote cardiac rhythm monitor evaluation, up to 30 days Review and analysis of data from a remote cardiac rhythm monitoring system over a period of up to 30 days. |
81 | $22 | $69 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
78 | $54 | $197 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
77 | $67 | $230 |
| Remote monitoring of implantable heart rhythm device Evaluation of data transmitted remotely from an implantable cardiovascular monitor, such as a loop recorder or subcutaneous cardiac rhythm monitor, over a period up to 30 days. |
72 | $52 | $89 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
63 | $128 | $447 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
55 | $13 | $43 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
53 | $8 | $13 |
| Remote evaluation of implantable defibrillator system Remote assessment of a single, dual, or multiple lead implantable defibrillator system within 90 days of the previous evaluation. |
46 | $29 | $98 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
42 | $194 | $675 |
| Continuous external EKG monitoring, 8-15 days This procedure involves recording heart rhythm continuously using an external EKG device over a period of 8 to 15 days. |
27 | $10 | $41 |
| External EKG monitoring, 8-15 days Continuous external electrocardiogram recording and review over a period of 8 to 15 days to monitor heart rhythm. |
27 | $19 | $70 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
21 | $10 | $32 |
| Technetium Tc-99m tetrofosmin diagnostic injection A diagnostic injection of Technetium Tc-99m tetrofosmin used for imaging studies. |
21 | $76 | $222 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
16 | $16 | $48 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
16 | $8 | $43 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
11 | $22 | $69 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
24.7% high complexity
20.0% medium
55.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,171
Total received (2018-2024)
Avg $1,310/year across 7 years
Top 29% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
44
Companies
513
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,929 (97.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$242 (2.6%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$722
2023
$1,623
2022
$1,787
2021
$204
2020
$612
2019
$2,519
2018
$1,704
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Boston Scientific Corporation
$107
Alnylam Pharmaceuticals Inc.
$105
Novartis Pharmaceuticals Corporation
$104
Amgen Inc.
$84
Boehringer Ingelheim Pharmaceuticals, Inc.
$68
Merck Sharp & Dohme LLC
$54
AstraZeneca Pharmaceuticals LP
$49
E.R. Squibb & Sons, L.L.C.
$40
Janssen Pharmaceuticals, Inc
$37
Bayer Healthcare Pharmaceuticals Inc.
$29
PFIZER INC.
$25
Kestra Medical Technology Services, Inc.
$19
Top 3 companies account for 43.8% of 2024 payments
All-time payments by company (2018-2024) ›
Amgen Inc.
$1,323
Novartis Pharmaceuticals Corporation
$952
BIOTRONIK INC.
$756
Boston Scientific Corporation
$602
Alnylam Pharmaceuticals Inc.
$569
PFIZER INC.
$528
SANOFI-AVENTIS U.S. LLC
$502
Janssen Pharmaceuticals, Inc
$468
E.R. Squibb & Sons, L.L.C.
$367
Boehringer Ingelheim Pharmaceuticals, Inc.
$344
Merck Sharp & Dohme LLC
$272
AstraZeneca Pharmaceuticals LP
$261
Medtronic, Inc.
$213
Medtronic Vascular, Inc.
$191
BOSTON SCIENTIFIC CORPORATION
$174
Regeneron Healthcare Solutions, Inc.
$171
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$149
ABIOMED
$141
Kiniksa Pharmaceuticals, Ltd.
$120
Kestra Medical Technology Services, Inc.
$114
Otsuka America Pharmaceutical, Inc.
$104
AngioDynamics, Inc.
$87
Abbott Laboratories
$82
Bayer Healthcare Pharmaceuticals Inc.
$74
Bayer HealthCare Pharmaceuticals Inc.
$59
Esperion Therapeutics, Inc.
$56
PORTOLA PHARMACEUTICALS, INC.
$43
Impulse Dynamics (USA) Inc.
$41
Chiesi USA, Inc.
$39
Celgene Corporation
$36
Philips Electronics North America Corporation
$35
Astellas Pharma US Inc
$32
Actelion Pharmaceuticals US, Inc.
$28
HeartFlow, Inc.
$26
Kowa Pharmaceuticals America, Inc.
$24
Cardiovascular Systems Inc.
$24
Novo Nordisk Inc
$24
Lundbeck LLC
$23
Gilead Sciences, Inc.
$23
Ethicon US, LLC
$23
Medtronic USA, Inc.
$20
Amarin Pharma Inc.
$18
iRhythm Technologies, Inc.
$16
ConvaTec Inc.
$15
Top 3 companies account for 33.0% of all-time payments
Associated products mentioned in payments ›
ACCOLADE SR · AMVUTTRA · ANDEXXA · AQUACEL AG · AQUAMANTYS · Allure CRT Pacemaker · Arcalyst · Assure WCD · BRILINTA · BYDUREON · CAMZYOS · CHANTIX · CardioMEMS HF System · Corlanor · ELIQUIS · EMBLEM · ENTRESTO · FARXIGA · FFRct · GENERAL BRADY · GENERAL TACHY · GENERAL - BRADY · GENERAL - TACHY · GENERAL - THERAPIES · GENERAL TACHY · General - Brady · General - Tachy · General - Therapies · GlideLight · Impella · JARDIANCE · KENGREAL · Kerendia · LEQVIO · LEXISCAN · LINQ II · LUX DX · LUX-Dx Insertable Cardiac Monitor · LifeVest · Livalo · MULTAQ · Micra · Microny ll SR plus Pacemaker · Mitra Clip system · NEXLETOL · NEXLIZET · NORTHERA · ONPATTRO · OPSUMIT MACITENTAN · Optimizer · Ozempic · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Peripheral Orbital Atherectomy System · RESONATE · Repatha · Resolute · SAMSCA · SURGICEL Family of Absorbable Hemostats · VENACURE 1470 PRO · VERQUVO · VYNDAQEL · Vascepa · WAINUA · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO · ZIO Patch
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
197
Per 100K population
6.2
County median income
$113,702
Nearest hospital
PROVIDENCE MISSION HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Rediker is a remote & electrophysiology specialist, with moderate Medicare volume, with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Rediker experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Rediker performed 483 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Rediker receive payments from pharmaceutical companies?
Yes. Dr. Rediker received a total of $9,171 from 44 companies across 513 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Rediker's costs compare to other cardiologists in Mission Viejo?
Dr. Rediker's average Medicare payment per service is $64. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Rediker) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Mission Viejo
Browse cardiologists in Mission Viejo ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
BIOTRONIK INC. Payments to Doctors
See all physicians who received payments from BIOTRONIK INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology